Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
- PMID: 37807924
- DOI: 10.1161/CIR.0000000000001184
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
Erratum in
-
Correction to: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.Circulation. 2024 Mar 26;149(13):e1023. doi: 10.1161/CIR.0000000000001241. Epub 2024 Mar 25. Circulation. 2024. PMID: 38527138 No abstract available.
Abstract
Cardiovascular-kidney-metabolic health reflects the interplay among metabolic risk factors, chronic kidney disease, and the cardiovascular system and has profound impacts on morbidity and mortality. There are multisystem consequences of poor cardiovascular-kidney-metabolic health, with the most significant clinical impact being the high associated incidence of cardiovascular disease events and cardiovascular mortality. There is a high prevalence of poor cardiovascular-kidney-metabolic health in the population, with a disproportionate burden seen among those with adverse social determinants of health. However, there is also a growing number of therapeutic options that favorably affect metabolic risk factors, kidney function, or both that also have cardioprotective effects. To improve cardiovascular-kidney-metabolic health and related outcomes in the population, there is a critical need for (1) more clarity on the definition of cardiovascular-kidney-metabolic syndrome; (2) an approach to cardiovascular-kidney-metabolic staging that promotes prevention across the life course; (3) prediction algorithms that include the exposures and outcomes most relevant to cardiovascular-kidney-metabolic health; and (4) strategies for the prevention and management of cardiovascular disease in relation to cardiovascular-kidney-metabolic health that reflect harmonization across major subspecialty guidelines and emerging scientific evidence. It is also critical to incorporate considerations of social determinants of health into care models for cardiovascular-kidney-metabolic syndrome and to reduce care fragmentation by facilitating approaches for patient-centered interdisciplinary care. This presidential advisory provides guidance on the definition, staging, prediction paradigms, and holistic approaches to care for patients with cardiovascular-kidney-metabolic syndrome and details a multicomponent vision for effectively and equitably enhancing cardiovascular-kidney-metabolic health in the population.
Keywords: AHA Scientific Statements; chronic kidney disease; diabetes; metabolic syndrome; obesity; risk prediction; social determinants of health.
Comment in
-
A united vision for cardiovascular-kidney-metabolic health.Nat Rev Nephrol. 2024 May;20(5):273-274. doi: 10.1038/s41581-024-00812-6. Nat Rev Nephrol. 2024. PMID: 38287135 No abstract available.
Similar articles
-
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association.Circulation. 2023 Nov 14;148(20):1636-1664. doi: 10.1161/CIR.0000000000001186. Epub 2023 Oct 9. Circulation. 2023. PMID: 37807920 Review.
-
Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association.Circulation. 2023 Dec 12;148(24):1982-2004. doi: 10.1161/CIR.0000000000001191. Epub 2023 Nov 10. Circulation. 2023. PMID: 37947094 Review.
-
Here's What to Know About Cardiovascular-Kidney-Metabolic Syndrome, Newly Defined by the AHA.JAMA. 2023 Dec 5;330(21):2042-2043. doi: 10.1001/jama.2023.22276. JAMA. 2023. PMID: 37938824
-
Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Stroke. 2012 Jul;43(7):1998-2027. doi: 10.1161/STR.0b013e31825bcdac. Epub 2012 May 24. Stroke. 2012. PMID: 22627990
-
The American Heart Association 2030 Impact Goal: A Presidential Advisory From the American Heart Association.Circulation. 2020 Mar 3;141(9):e120-e138. doi: 10.1161/CIR.0000000000000758. Epub 2020 Jan 29. Circulation. 2020. PMID: 31992057 Free PMC article.
Cited by
-
Cardiovascular-Kidney-Metabolic Syndrome Among Healthcare Workers in Chinese Tertiary Hospital.Risk Manag Healthc Policy. 2024 Nov 2;17:2647-2657. doi: 10.2147/RMHP.S488289. eCollection 2024. Risk Manag Healthc Policy. 2024. PMID: 39525684 Free PMC article.
-
Semaglutide cuts kidney risk in obesity.J Endocrinol Invest. 2024 Nov 4. doi: 10.1007/s40618-024-02494-0. Online ahead of print. J Endocrinol Invest. 2024. PMID: 39495477 No abstract available.
-
Software-driven chronic disease management: Algorithm design and implementation in a community-based blood pressure control pilot.SAGE Open Med. 2024 Oct 31;12:20503121241284025. doi: 10.1177/20503121241284025. eCollection 2024. SAGE Open Med. 2024. PMID: 39494161 Free PMC article.
-
Preterm Birth and Kidney Health: From the Womb to the Rest of Life.Children (Basel). 2024 Oct 2;11(10):1213. doi: 10.3390/children11101213. Children (Basel). 2024. PMID: 39457178 Free PMC article. Review.
-
A novel model of cardiovascular-kidney-metabolic syndrome combining unilateral nephrectomy and high-salt-sugar-fat diet in mice.Lab Anim (NY). 2024 Nov;53(11):336-346. doi: 10.1038/s41684-024-01457-5. Epub 2024 Oct 22. Lab Anim (NY). 2024. PMID: 39438661 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
